ANTINEOPLASTIC AGENTS
Clinical trials for ANTINEOPLASTIC AGENTS explained in plain language.
Never miss a new study
Get alerted when new ANTINEOPLASTIC AGENTS trials appear
Sign up with your email to follow new studies for ANTINEOPLASTIC AGENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart treatment trial aims to reduce bleeding risk in elderly patients
Disease control Recruiting nowThis international study is testing whether using just one blood-thinning medication is as safe and effective as using two after a specific type of heart artery procedure. It focuses on patients aged 75 and older or those at high risk for bleeding. The goal is to find the best ba…
Matched conditions: ANTINEOPLASTIC AGENTS
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug tested for Tough-to-Treat kidney cancer
Disease control Recruiting nowThis study is observing how well the drug vorolanib works and how safe it is for patients with advanced kidney cancer that has spread or cannot be removed by surgery. It involves 39 adults who are receiving vorolanib as their second treatment option. Researchers will track how lo…
Matched conditions: ANTINEOPLASTIC AGENTS
Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
Poop pills tested to fight cancer drug sickness
Symptom relief Recruiting nowThis study is testing if a fecal microbiota transplant (FMT), which transfers healthy gut bacteria from a donor, can help reduce nausea, vomiting, and diarrhea caused by chemotherapy or targeted therapy. It will involve 90 adults with advanced gastrointestinal cancers who have al…
Matched conditions: ANTINEOPLASTIC AGENTS
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Mar 23, 2026 15:15 UTC